These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6775071)

  • 1. Protection of congenitally athymic mice against Trypanosoma cruzi infection by passive antibody transfer.
    Kierszenbaum F
    J Parasitol; 1980 Aug; 66(4):673-5. PubMed ID: 6775071
    [No Abstract]   [Full Text] [Related]  

  • 2. Corpus Christi strain-induced protection to Trypanosoma cruzi infection in C3H(He) mice: transfer of resistance to Brazil strain challenge with lymphocytes.
    Rowland EC; Ritter DM
    J Parasitol; 1984 Oct; 70(5):760-6. PubMed ID: 6439846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of resistance against experimental Trypanosoma cruzi infection: the importance of antibodies and antibody-forming capacity in the Biozzi high and low responder mice.
    Kierszenbaum F; Howard JG
    J Immunol; 1976 May; 116(5):1208-11. PubMed ID: 818311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against Trypanosoma cruzi using fecal forms of homologous parasites from juvenilized or normal vectors of Chagas' disease and by passive transfer of immune blood.
    Perlowagora-Szumlewicz A
    Rev Bras Malariol Doencas Trop; 1977; 29():5-21. PubMed ID: 120952
    [No Abstract]   [Full Text] [Related]  

  • 5. 75Se-methionine labelled Trypanosoma cruzi blood trypomastigotes: opsonization by chronic infection serum facilitates killing in spleen and liver.
    Scott MT; Moyes L
    Clin Exp Immunol; 1982 Jun; 48(3):754-7. PubMed ID: 6811174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytophilic antibody in experimental Chagas' disease.
    Kuhn RE; Cassida GW
    J Parasitol; 1981 Dec; 67(6):807-12. PubMed ID: 6799634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function.
    Miller MJ; Wrightsman RA; Stryker GA; Manning JE
    J Immunol; 1997 Jun; 158(11):5330-7. PubMed ID: 9164953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing antibodies in Trypanosoma cruzi infection.
    Sánchez DO; González Cappa SM
    Medicina (B Aires); 1983; 43(1):41-6. PubMed ID: 6410148
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of extracts rich in immune RNA on some immunopathological parameters of rats infected with Trypanosoma cruzi].
    Revelli S; Moreno H; Berra H; Velenti JL; Nocito A; Amerio N; Morini JC
    Bol Chil Parasitol; 1985; 40(3-4):51-7. PubMed ID: 3939407
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoclonal antibodies mediating viable immunofluorescence and protection against Trypanosoma cruzi infection.
    Heath AW; Martins MS; Hudson L
    Trop Med Parasitol; 1990 Dec; 41(4):425-8. PubMed ID: 2127473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Trypanosoma cruzi autoreactive T cells in the generation of cardiac pathology.
    Gironès N; Carrasco-Marin E; Cuervo H; Guerrero NA; Sanoja C; John S; Flores-Herráez R; Fernández-Prieto L; Chico-Calero I; Salgado H; Carrión J; Fresno M
    Ann N Y Acad Sci; 2007 Jun; 1107():434-44. PubMed ID: 17804572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of cytolytic antibody in experimental Chagas' disease using a terminal radiolabelling procedure.
    Powell MR; Kuhn RE
    J Parasitol; 1980 Jun; 66(3):399-406. PubMed ID: 6771377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
    Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
    Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunization against Trypanosoma cruzi and tumor growth in mice].
    Kallinikova VD; Borisova EN; Pakhorukova LV; Ogloblina TA; Batmonkh Ts; Kravtsov EG; Karpenko LP; Dalin MV
    Med Parazitol (Mosk); 2006; (4):9-12. PubMed ID: 17290901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Trypanosoma cruzi infection in congenitally athymic mice].
    Segura EL; Esteva M; Quintans CJ; Montoro LS; Weissenbacher MC
    Medicina (B Aires); 1981; 41(3):328-32. PubMed ID: 6798364
    [No Abstract]   [Full Text] [Related]  

  • 16. Protection against challenge of mice experimentally infected with Trypanosoma cruzi.
    Szarfman A; Schmuñis GA; Vattuone NH; Yanovsky JF; Cossio PM; Arana RM
    Tropenmed Parasitol; 1977 Sep; 28(3):333-41. PubMed ID: 410127
    [No Abstract]   [Full Text] [Related]  

  • 17. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance.
    Nickell SP; Sharma D
    Exp Parasitol; 2000 Apr; 94(4):207-16. PubMed ID: 10831388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nature of immunity against Trypanosoma cruzi in mice recovered from acute infection.
    Scott MT
    Parasite Immunol; 1981; 3(3):209-18. PubMed ID: 6795575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune system pathogenesis is prevented by the neutralization of the systemic trans-sialidase from Trypanosoma cruzi during severe infections.
    Risso MG; Pitcovsky TA; Caccuri RL; Campetella O; Leguizamón MS
    Parasitology; 2007 Apr; 134(Pt 4):503-10. PubMed ID: 17166319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma cruzi antibodies in mice infected with different strains of T.cruzi.
    Peralta JM; Filardi L; Loures MA; Torres ST
    J Parasitol; 1980 Apr; 66(2):342-4. PubMed ID: 6771373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.